DBV Technologies Profile

44.74
USD 0.00  0.00%
1%
0%

DBV Technologies S Risk Profiles

Key Fundamentals

DBV Technologies Against Markets

DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. DBV Technologies S.A. was founded in 2002 and is headquartered in Montrouge, France. DBV Technologies operates under Biotechnology classification in USA and traded on OTC Market. It employs 244 people. more
NameDBV Technologies S A
Chairman of the Board, CEOPierreHenri BenhamouView All
Macroaxis Advice
InstrumentUSA Stock View All
Business Address177-181 avenue Pierre Brossolette
ExchangeOTC Market
SectorHealthcare
BenchmarkDOW
Websitewww.dbv-technologies.com
Phone33 1 55 42 78 78
CurrencyUSD - US Dollar

DBV Technologies Corporate Directors

Rafaele Tordjman Director - Representative of Sofinnova Partners
Pascale Ehouarn Industrial Development and Production Director
Claude Thebault Medical Director
Additionally see Investing Opportunities. Please also try Aroon Oscillator module to analyze current equity momentum using aroon oscillator and other momentum ratios.